RESUMO
Ependymomas were produced in 44 of 50 Syrian golden hamsters and in 9 of 31 outbred Swiss mice inoculated intracerebrally with high-titer, purified BK virus (BKV). Tumors contained a T-antigen that reacted with BKV-specific T-antibody in immunofluorescence and complement-fixation tests. A proportion of tumor-bearing animals had antibodies to BKV T-antigen in their sera. BKV could be rescued from two tumor cell lines by Sendal virus-mediated fusion with Vero cells. A low, or lack of, oncogenic activity was displayed by BKV inoculated sc, ip, or iv.
Assuntos
Neoplasias Encefálicas/etiologia , Ependimoma/etiologia , Infecções Tumorais por Vírus/etiologia , Animais , Animais Recém-Nascidos , Antígenos Virais , Vírus BK/imunologia , Neoplasias Encefálicas/imunologia , Cricetinae , Ependimoma/imunologia , Células Híbridas/imunologia , Mesocricetus , Camundongos , Neoplasias Experimentais/etiologia , Sarcoma Experimental/etiologia , Sarcoma Experimental/imunologiaRESUMO
The aim of this study was to analyze (i) phenotype, (ii) in vitro spontaneous and induced apoptosis, (iii) glutathione (GSH) intracellular content and (iv) inhibitors of apoptosis of potential therapeutical use in peripheral blood mononuclear cells (PBMC) from HIV+ long term non progressors (LTNP), in comparison with progressors (HIV+P) and seronegative controls (HIV-). Three groups of subjects were studied: 15 HIV+P (patients losing >150 CD4+/year), 9 LTNP (subjects infected by HIV for at least 7 years without clinical and immunological signs of progression, with a mean of 898 CD4+/microL) and 18 HIV-. All subjects were living in a large community for former drug addicts, and were matched for age and sex. We used flow cytometry for analyzing PBMC phenotype and apoptosis; high performance liquid chromatography for measuring intracellular GSH content. PBMC phenotype of LTNP shared characteristics with those of both HIV- and HIV+P. Indeed, LTNP showed a normal number CD4+ cells (an inclusion criteria), but significantly increased numbers of CD8+ lymphocytes, activated T cells, CD19+, CD5+ B lymphocytes and CD57+ cells, as well as a decrease in CD19+, CD5- B lymphocytes and CD16+ cells. In LTNP, spontaneous apoptosis was similar to that of HIV- and significantly lower than that of HIV+P. Adding interleukin-2 (IL-2) or nicotinamide (NAM) significantly decreased spontaneous apoptosis in LTNP and HIV+P. Pokeweed mitogen-induced apoptosis was also similar in LTNP and HIV-, but significantly lower than that of HIV+P. In HIV+P, but also in LTNP, spontaneous apoptosis was inversely correlated to the absolute number and percentage of CD4+ cells and directly correlated to the number and percentage of activated T cells present in peripheral blood. GSH intracellular content was greatly decreased in PBMC from HIV+P and slightly, but significantly, reduced in LTNP. Adding 2-deoxy-D-ribose, an agent provoking apoptosis through GSH depletion, to quiescent PBMC resulted in similar levels of massive cell death in the three groups. This phenomenon was equally prevented in the three groups by N-acetyl-cysteine but not by IL-2. A complex immunological situation seems to occur in LTNP. Indeed, PBMC from LTNP are characterized by a normal in vitro tendency to undergo apoptosis despite the presence of a strong activation of their immune system, unexpectedly similar to that of HIV+P. Our data suggest that NAM and IL-2 are possible candidates for reducing spontaneous apoptosis in HIV infection.
RESUMO
HepG2 cells, a well differentiated liver cell line, were shown to be permissive for both human herpesvirus 6 (HHV-6) A and B strains by three independent methods of analysis: detection of viral antigens, viral DNA sequences and infectious virus. HepG2 cell infection with HHV-6 resulted in functional damage as shown by the increased release in the culture medium of some hepatocyte markers. Cells surviving the acute infection were serially passaged without showing cytopathic effect, but, some months later, HHV-6 DNA was still present in the cells and virus induction with a phorbol ester was successful. A possible pathogenetic role of HHV-6 in liver diseases is discussed. Experiments of HepG2 infection with human herpesvirus 7 (HHV-7) were also carried out. The lack of an efficient virus replication suggested a difficulty for HHV-7 to infect hepatic cells.
Assuntos
Herpesvirus Humano 6/crescimento & desenvolvimento , Herpesvirus Humano 7/crescimento & desenvolvimento , Células Cultivadas , Efeito Citopatogênico Viral , DNA Viral/análise , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Sangue Fetal/citologia , Herpesvirus Humano 6/genética , Herpesvirus Humano 6/metabolismo , Humanos , Células Tumorais Cultivadas , Proteínas Virais/genética , Proteínas Virais/metabolismoRESUMO
The antibody content to HIV-1 p24 Ag expressed as relative binding capacity to the target antigen (p24 RBC) was retrospectively quantified in serum samples from 20 HIV-1-uninfected infants born to HIV-1 seropositive mothers. p24 RBC values quantified at birth were included either in a low (0-20%) or high (80-100%) range of values, classified as group A (11 infants) and group B (9 infants), respectively. The course of maternal antibodies to HIV-1 antigens p17, p24, p31, gp41, p51, p66, gp120, and gp160 was studied in each group. A substantial difference in the amount and subsequently in the decline of maternal antibodies to gag proteins p17, p24, and p55 and to pol proteins p51 and p66 was observed in the two infant groups in contrast with a similar content and decline of the remaining antibodies. In 7 HIV-1-infected infants of whom 4 resembled infant group A and 3 infant group B for p24 RBC values, a relationship appeared between p24 antibody decline and p24 antigenemia detection.
Assuntos
Anticorpos Anti-HIV/imunologia , Proteína do Núcleo p24 do HIV/imunologia , Infecções por HIV/imunologia , HIV-1/imunologia , Biomarcadores , Feminino , Anticorpos Anti-HIV/sangue , Proteína do Núcleo p24 do HIV/sangue , Infecções por HIV/sangue , Infecções por HIV/transmissão , Soropositividade para HIV/imunologia , Humanos , Lactente , Recém-Nascido , Transmissão Vertical de Doenças Infecciosas , Mães , Estudos RetrospectivosRESUMO
BACKGROUND AND AIMS: Herpesviruses infect the liver and cause minor hepatitis. Our aim is to verify the presence of herpesviruses in the liver from hepatitis C patients and the possible influence of these viruses in the liver disease. METHODS: We searched for herpesvirus DNA in liver biopsies from patients with hepatitis C and from a control group without hepatitis by means of nested polymerase chain reaction. Serological investigations were carried out as well. RESULTS: Thirty-four liver specimens from hepatitis C patients were examined, 12 of which (35.3%) were positive for at least one herpesvirus DNA, whereas among the 19 control specimens only two were positive (10.5%; P = 0.049). Liver biopsies from seven patients, three with acute hepatitis of unknown origin, three with non-alcoholic steatohepatitis and one with autoimmune hepatitis were also investigated and three positive samples were found. CONCLUSIONS: The prevalence of herpesvirus DNA was found higher in patients with hepatitis C than in individuals without hepatitis. The influence of herpesviruses on the clinical course of hepatitis C is considered.
Assuntos
DNA Viral/análise , Hepatite C/virologia , Infecções por Herpesviridae/virologia , Herpesviridae/química , Fígado/virologia , Adulto , Anticorpos Antivirais/sangue , Feminino , Hepatite C/complicações , Hepatite C/imunologia , Herpesviridae/imunologia , Infecções por Herpesviridae/complicações , Infecções por Herpesviridae/imunologia , Humanos , Fígado/química , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Testes SorológicosRESUMO
Nalidixic acid and oxolinic acid, two antibacterial agents known to inhibit bacterial DNA gyrase, are shown to suppress the replication, as well as the cytopathic effect, of BK virus in Vero cell cultures. The inhibition of virus replication was detectable at day 4 post infection in cultures which had been continuously exposed to drugs at concentrations as low as 0.02 to 0.04 mM of nalidixic acid and 0.2 mM of oxolinic acid. These active concentrations are inferior to plasma levels attained in the course of clinical use of the drugs for antibacterial chemotherapy. Also, under these circumstances, no cytotoxicity occurred. The inhibition of development of cytopathology and of virus-induced cell death was demonstrable in cultures treated for 12 days with the drugs. Under these circumstances of prolonged action, oxolinic acid proved to be slightly cytotoxic in that virus inhibitory doses reduced the viability of normal cells. No alterations in the topological conformation of the viral genome or accumulation of end products of viral DNA replication were detected. However, accumulation of viral DNA form I at 48 h post infection suggests that the drugs act through a mechanism involving DNA topoisomerase.
Assuntos
Vírus BK/efeitos dos fármacos , Ácido Nalidíxico/farmacologia , Ácido Oxolínico/farmacologia , Polyomavirus/efeitos dos fármacos , Inibidores da Topoisomerase II , Replicação Viral/efeitos dos fármacos , Antígenos Virais/biossíntese , Efeito Citopatogênico Viral , DNA Viral/biossínteseRESUMO
Papanicolaou (Pap)-stained cervical specimens from 160 squamous lesions were processed for the detection of human papillomavirus (HPV) DNA by an in situ hybridization (ISH) assay. Three biotinylated HPV DNA probes were employed, each containing HPV genotypes 6/11, HPV genotypes 16/18, or HPV genotypes 31/35/51. The HPV etiology of 86 lesions was ascertained (53.8%). In 74 out of 135 (58.8%) HPV-typed low-grade squamous intraepithelial lesions (SILs), HPV 6/11 was found in nine (6.6%), HPV 16/18 in 46 (34.2%), and HPV 31/35/51 in 19 lesions (14.1%); in 11 out of 18 HPV-typed high-grade SILs (61.1%), seven lesions (38.9%) were typed for HPV 16/18 and four (22.2%) for HPV 31/35/51. Of seven invasive carcinomas, only one (14.3%) reacted with the HPV 16/18 DNA probe. A cohort of 124 low-grade SILs were followed cytologically for a year. The results of this study are discussed in light of HPV type association and therapy.
Assuntos
Papillomaviridae/classificação , Papillomaviridae/isolamento & purificação , Neoplasias do Colo do Útero/virologia , DNA Viral/análise , Feminino , Humanos , Hibridização In Situ , Neoplasias de Células Escamosas/terapia , Neoplasias de Células Escamosas/virologia , Infecções por Papillomavirus/virologia , Estudos Prospectivos , Infecções Tumorais por Vírus/virologia , Neoplasias do Colo do Útero/terapia , Displasia do Colo do Útero/terapia , Displasia do Colo do Útero/virologiaRESUMO
Archived Papanicolaou-stained cervical smears from women with different cervical pathologies were processed for human papillomavirus (HPV) DNA detection and typing with an in situ hybridization (ISH) assay that employed commercial biotinylated HPV DNA probes. Two HPV DNA probes were utilized: one included HPV genotypes 6/11 and the other, 16/18. The method yielded positive results for HPV DNA 6/11 in 5 cases with condylomata acuminata (100%) and in 2 of 47 with flat warty lesions (4.2%), whereas HPV DNA 16/18 was detected in 29/47 of the latter group (61.7%). In cases with cervical intraepithelial III or invasive squamous cell carcinoma the yield was lower: positive results for HPV DNA 16/18 were obtained in only one of the five cases with one or the other cervical pathology (20%). An analysis of the results showed that the sensitivity of the assay correlated with evidence in the Papanicolaou specimens of pathognomonic cell injury from HPV infection. In the presence of such cytologic features, HPV DNA typing was possible in 37/52 cases (65.4%). In view of the modest difficulty and relatively quick execution of the nonradioactive ISH assay, the authors believe that Papanicolaou cervical smears with cytologic changes of HPV infection could be processed by this method in order to acquire information on the HPV type or types involved in the cervical infection.
Assuntos
Hibridização de Ácido Nucleico , Papillomaviridae/isolamento & purificação , Infecções Tumorais por Vírus/genética , Doenças do Colo do Útero/microbiologia , Sondas de DNA de HPV , DNA Viral/análise , Feminino , Humanos , Teste de Papanicolaou , Papillomaviridae/classificação , Esfregaço VaginalRESUMO
546 human sera from healthy subjects, subjects with cytomegalovirus or Epstein-Barr virus infection and from cordal blood were tested for the human herpesvirus-6 (HHV-6) IgG content in an enzyme-linked immunosorbent assay (ELISA) to verify results previously obtained with an immunofluorescence assay (IFA). The HHV-6 isolate CV, obtained from a child with exanthem subitum, employed as antigen in both tests, belonged to HHV-6 variant B. The ELISA results were similar to those obtained with IFA. 445/546 (81.5%) sera had the same type of reactivity with the two serological procedures. To establish whether different HHV-6 strains may give different serological results, 117 out of the 546 sera tested with IFA against CV infected cells were also tested against cells infected with the HHV-6 isolate U1102 belonging to variant A. All the sera showed a similar reactivity.
Assuntos
Anticorpos Antivirais/sangue , Ensaio de Imunoadsorção Enzimática , Imunofluorescência , Herpesvirus Humano 6/imunologia , Adolescente , Criança , Pré-Escolar , Infecções por Herpesviridae/imunologia , Humanos , Imunoglobulina G/sangue , Lactente , Recém-Nascido , Pessoa de Meia-IdadeRESUMO
The surface antigenic make-up of 10 HHV-6 isolates from cases of infantile disease was analyzed by immunofluorescence assay with 5 monoclonal antibodies (Mabs). Three Mabs were directed to glycoproteins (gps) expressed in cells infected with the HHV-6 variant A prototype GS, and 2 to gps expressed in cells infected with the HHV-6 variant B prototype Z29. Of the 10 viral isolates, all belonging to HHV-6 variant B, 9 showed a similar Mab reactivity, while 1, from a case of gastroenteric illness, differed widely from the others. The HHV-6 isolates studied also differed from the variant B prototype Z29 for the absence of reactivity to one of the Mabs. The choice of the HHV-6 new isolates as variant B prototypes is recommended.
Assuntos
Antígenos Virais/imunologia , Febre/microbiologia , Variação Genética , Infecções por Herpesviridae/microbiologia , Herpesvirus Humano 6/imunologia , Anticorpos Monoclonais/imunologia , Anticorpos Antivirais/imunologia , Antígenos Virais/genética , Imunofluorescência , Infecções por Herpesviridae/genética , Infecções por Herpesviridae/imunologia , Herpesvirus Humano 6/genética , Herpesvirus Humano 6/isolamento & purificação , Humanos , LactenteRESUMO
Sera from a sample of children aged 3 months to 6 years and from cord blood were tested in an indirect immunofluorescence assay (IFA) for reactivity to human herpesviruses 6 (HHV-6) and 7 (HHV-7). HHV-6 seropositivity values rose from 19% to 79.3% in the first 18 months of life, while HHV-7 seroprevalence reached a similar value (75.9%) in children aged 3-6 years. These results show that HHV-7, like HHV-6, is a prevalent virus in infancy. In cord blood sera, assayed to study infant humoral situation at birth, similar values for the two viruses (78.9% for HHV-6 and 76.3% for HHV-7) were found. HHV-6 and HHV-7 IgG antibody affinity to the corresponding antigens was assessed by the end point antibody titration in the presence and absence of urea 8M. This test distinguishes antibodies of recent (low affinity) or past (high affinity) production. Together, the data on seroprevalence and antibody affinity suggest that HHV-6 primary infection generally precedes that by HHV-7. These results are discussed in the light of a different pathogenetic role of the two viruses.
Assuntos
Anticorpos Antivirais/sangue , Infecções por Herpesviridae/epidemiologia , Herpesvirus Humano 6/imunologia , Herpesvirus Humano 7/imunologia , Afinidade de Anticorpos , Criança , Pré-Escolar , Técnica Indireta de Fluorescência para Anticorpo , Infecções por Herpesviridae/sangue , Humanos , Imunoglobulina G/sangue , Lactente , Recém-Nascido , Itália/epidemiologia , Prevalência , Fatores de TempoRESUMO
Forty-five sera from men with bladder cancer were examined in a micro solid-phase enzyme-linked immunosorbent assay (ELISA) and in a Western-blotting (WB) assay for the presence of IgG antibodies to papillomavirus (PV) genus-antigens of bovine origin. The ELISA detected PV antibodies in 75.6% of cancer patients. This antibody frequency was significantly higher than that found in both healthy males (22.7%) and patients with urological disorders (24%). A similar correlation among the PV antibody frequencies of the three groups was found with WB assay: 60% of the neoplastic group showed PV antibodies versus 17.3% in healthy males and 32.6% in non-neoplastic patients. Within the same group, 78% to 87% sera showed the same reactivity to both assays. Of these concordant sera, PV positive sera were 55.6% in cancer patients, 13.3% in healthy adults and 19.6% in patients with urological disorders. ELISA PV antibody level in the cancer group was higher than in each of the two control groups. The meaning of the humoral response to PV genus-antigens in men with bladder cancer is discussed.
Assuntos
Imunoglobulina G/sangue , Papillomaviridae/imunologia , Infecções por Papillomavirus/complicações , Infecções Tumorais por Vírus/complicações , Neoplasias da Bexiga Urinária/complicações , Adulto , Animais , Anticorpos Antivirais/sangue , Antígenos Virais de Tumores/imunologia , Western Blotting , Carcinoma Papilar/complicações , Carcinoma Papilar/imunologia , Bovinos , Criança , Pré-Escolar , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Lactente , Masculino , Papillomaviridae/isolamento & purificação , Infecções por Papillomavirus/imunologia , Infecções Tumorais por Vírus/imunologia , Neoplasias da Bexiga Urinária/imunologia , Doenças Urológicas/complicações , Doenças Urológicas/imunologiaRESUMO
In the years 1999-2001, 868 samples of cerebrospinal fluid (CSF) from as many patients with acute neurological manifestations of suspected viral origin were analysed for the presence of viruses at the Centre for the Diagnosis of Viral Diseases of the University of Modena and Reggio Emilia. Neurological patients included 788 immunocompetent subjects and 80 patients with impaired immunity due to human immunodeficiency virus (HIV) seropositivity. Of the CSF samples, 125 (15.8%) were positive for one or more viruses among the immunocompetent patients, whereas 33 (41.1%) were positive among the HIV cohort. DNA and RNA viruses were detected in the first group of CSF samples whereas only DNA viruses were found in the second group. In immunocompetent patients the frequency of enteroviruses prevailed over that of other RNA virus families (p = 0.001) and that of herpesviruses over the frequency of other DNA virus families (p = 0.001). Among herpesvirus members, the Epstein-Barr gamma-herpesvirus prevailed on alpha-herpesviruses in each of the two groups of patients (p = 0.05 in the immunocompetent group and p = 0.006 in HIV-positive patients). The clinical relevance both of this virus and of beta-herpesviruses as a cause of neurological disorders is discussed.
Assuntos
Betaherpesvirinae/isolamento & purificação , Líquido Cefalorraquidiano/virologia , Gammaherpesvirinae/isolamento & purificação , Infecções por Herpesviridae/virologia , Doenças do Sistema Nervoso/etiologia , Alphaherpesvirinae/isolamento & purificação , Vírus de DNA/isolamento & purificação , Enterovirus/isolamento & purificação , Humanos , Vírus de RNARESUMO
HHV-7 growth on Sup-T1, an immature T-cell line, was studied using different HHV-7 isolates obtained in our laboratory. Titration of viral yields showed that all the virus isolates propagate on this cell line more efficiently than in cord blood lymphocytes, the cells usually recommended for HHV-7 growth. The permissivity of Sup-T1 to HHV-6, whose ability to replicate in these cells was still unknown, was also investigated using two virus isolates representative of variants A and B respectively. Both isolates were able to propagate on Sup-T1 and viral titres were similar to those obtained in cord blood lymphocytes. As the efficient propagation of both HHV-7 and HHV-6 isolates in Sup-T1 cultures, these cells may replace more time consuming and expensive cord blood lymphocyte preparations for the propagation of both the viruses.
Assuntos
Herpesvirus Humano 6/crescimento & desenvolvimento , Herpesvirus Humano 7/crescimento & desenvolvimento , Linfócitos T/virologia , Cultura de Vírus/métodos , Linhagem Celular , Células Cultivadas , Sangue Fetal , Humanos , Linfócitos/virologiaRESUMO
We report nine cases of clinical manifestations by Toscana virus (TOSV) diagnosed at the Centre for the Diagnosis of Viral Diseases of the University of Modena and Reggio Emilia, in the inhabitants of Modena province (Emilia Romagna region), in the triennium 1999-2001. TOSV was involved in six cases of meningitis, two of meningoencephalitis and one case of febrile erythema without meningeal manifestations. Six TOSV-infected patients had stayed for a few days in a different area of the Tuscany region before the onset of clinical manifestations so, only three cases of infections by TOSV had an autochthonous origin.
Assuntos
Febre por Flebótomos/epidemiologia , Vírus da Febre do Flebótomo Napolitano , Humanos , Imunoglobulina G/análise , Imunoglobulina M/análise , Itália/epidemiologia , Febre por Flebótomos/imunologiaRESUMO
This note reports the finding of human herpes virus 8 DNA in the cerebrospinal fluid of a woman with sensory impairment correlated with a basal disease suspected to be multiple sclerosis.
Assuntos
Infecções por Herpesviridae/líquido cefalorraquidiano , Infecções por Herpesviridae/diagnóstico , Herpesvirus Humano 8/isolamento & purificação , Esclerose Múltipla/líquido cefalorraquidiano , Esclerose Múltipla/virologia , Adulto , DNA Viral/análise , DNA Viral/líquido cefalorraquidiano , Feminino , Herpesvirus Humano 8/genética , Humanos , Transtornos de Sensação/líquido cefalorraquidiano , Transtornos de Sensação/virologiaRESUMO
Fifty four cerebrospinal fluid samples obtained from as many immunocomponent patients with disorders of the central nervous system were investigated for the presence of herpesvirus DNA by nested polymerase chain reaction in order to determine an etiological diagnosis. Four of these samples proved positive for the presence of Epstein-Barr virus DNA (7.4%). The result of this diagnostic study is reported to draw insiders' attention to the possible presence of EBV in cerebrospinal fluid from patients with central nervous system diseases.
Assuntos
Encefalopatias/virologia , DNA Viral/líquido cefalorraquidiano , Infecções por Herpesviridae/virologia , Herpesvirus Humano 4/isolamento & purificação , Adulto , Idoso , Encefalopatias/líquido cefalorraquidiano , Herpesviridae/genética , Herpesviridae/isolamento & purificação , Infecções por Herpesviridae/líquido cefalorraquidiano , Herpesvirus Humano 4/genética , Humanos , Imunocompetência , Pessoa de Meia-Idade , Reação em Cadeia da PolimeraseRESUMO
Twenty five cases of meningitis occurred in urban areas surrounding a city (Modena) in Northern Italy, in the period May-July 1999. When the patients were admitted to the Infectious Diseases Division of the University of Modena and Reggio Emilia Hospital and studied by virological and serological methods, the meningitis proved to have an enteroviral origin and enterovirus ECHO 4 type was responsible for all cases of illness. An epidemiological characteristic of the enteroviral meninigitis outbreak was the adult age in 23 out of the 25 patients (mean age 24.50 +/- 7.84 years). The monthly distribution of the aseptic meningitis cases was the following: five cases occurred in May, 13 in June and seven in July. The origin of the spread of the virus infection and the reason for its sudden end remained unknown. The unusual drop in temperature which occurred in the geographic area involved in the aseptic meningitis outbreak at the beginning of August could have interfered with the slowdown in virus circulation.
Assuntos
Surtos de Doenças , Infecções por Echovirus/epidemiologia , Infecções por Echovirus/virologia , Enterovirus Humano B/isolamento & purificação , Meningite Asséptica/epidemiologia , Meningite Asséptica/virologia , Adolescente , Adulto , Animais , Anticorpos Monoclonais , Anticorpos Antivirais/análise , Criança , Chlorocebus aethiops , Infecções por Echovirus/líquido cefalorraquidiano , Enterovirus Humano B/genética , Ensaio de Imunoadsorção Enzimática , Fezes/virologia , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Humanos , Itália/epidemiologia , Masculino , Meningite Asséptica/líquido cefalorraquidiano , Reação em Cadeia da Polimerase , Prevalência , Células Vero/virologiaRESUMO
The association of a human herpesvirus 6 primary infection with a fatal case of hemophagocytic syndrome in a 3 month old baby is described. The trigger mechanism of the virus for the clinical syndrome is discussed.
Assuntos
Herpesvirus Humano 6/isolamento & purificação , Histiocitose de Células não Langerhans/diagnóstico , Animais , Anticorpos Antivirais/análise , Células Cultivadas , Chlorocebus aethiops , DNA Viral/análise , Ensaio de Imunoadsorção Enzimática , Feminino , Fibroblastos , Herpesviridae/imunologia , Herpesvirus Humano 6/genética , Herpesvirus Humano 6/imunologia , Histiocitose de Células não Langerhans/líquido cefalorraquidiano , Humanos , Imunoglobulina G/análise , Imunoglobulina M/análise , Lactente , Reação em Cadeia da Polimerase , Células VeroRESUMO
Routine search for herpesvirus types 1-5 by nested polymerase chain reaction revealed Epstein-Barr virus (EBV) DNA in the cerebrospinal fluid (CSF) of ten out of seventy-nine patients with human immunodeficiency virus (HIV) infection and central nervous system (CNS) disorders not associated with the presence of primary CNS lymphomas. One out of the ten CSF samples was positive for EBV DNA only, six were also positive for microbial agents of recognised neurological pathogenicity while the remaining three samples had a high content of HIV p24 Ag. When six available CSF samples out of the ten EBV DNA positive specimens were investigated for an intrathecal EBV antibody response, all six samples proved EBV antibody-free. The concurrent detection of neurotropic infectious agents and the absence of EBV antibodies in the CSF contribute to the uncertainty on the role of EBV in the neurological illness of the patients studied. One hypothesis considered is that the presence of EBV DNA in the CSF of a large fraction of the ten patients under study is an incidental event associated with EBV reactivation in the host's peripheral blood monocytes, but not related to the genesis of neurological disorders.